News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,353 Results
Type
Article (50146)
Company Profile (466)
Press Release (680741)
Multimedia
Podcasts (91)
Webinars (13)
Section
Business (210573)
Career Advice (2072)
Deals (36238)
Drug Delivery (110)
Drug Development (85175)
Employer Resources (174)
FDA (16682)
Job Trends (15218)
News (356774)
Policy (33581)
Tag
Academia (2782)
Academic (1)
Accelerated approval (6)
Adcomms (27)
Allergies (89)
Alliances (51699)
ALS (103)
Alzheimer's disease (1454)
Antibody-drug conjugate (ADC) (157)
Approvals (16656)
Artificial intelligence (288)
Autoimmune disease (28)
Automation (17)
Bankruptcy (376)
Best Places to Work (11919)
BIOSECURE Act (20)
Biosimilars (110)
Biotechnology (351)
Bladder cancer (85)
Brain cancer (28)
Breast cancer (308)
Cancer (2466)
Cardiovascular disease (195)
Career advice (1731)
Career pathing (30)
CAR-T (179)
Cell therapy (499)
Cervical cancer (21)
Clinical research (68915)
Collaboration (916)
Company closure (2)
Compensation (581)
Complete response letters (26)
COVID-19 (2731)
CRISPR (49)
C-suite (270)
Cystic fibrosis (107)
Data (2393)
Decentralized trials (2)
Denatured (31)
Depression (53)
Diabetes (280)
Diagnostics (6536)
Digital health (20)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (131)
Drug pricing (116)
Drug shortages (27)
Duchenne muscular dystrophy (105)
Earnings (88772)
Editorial (43)
Employer branding (21)
Employer resources (148)
Events (117614)
Executive appointments (770)
FDA (18094)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (817)
Gene editing (123)
Generative AI (22)
Gene therapy (362)
GLP-1 (771)
Government (4593)
Grass and pollen (4)
Guidances (167)
Healthcare (19366)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (145)
Indications (30)
Infectious disease (2882)
Inflammatory bowel disease (151)
Inflation Reduction Act (12)
Influenza (54)
Intellectual property (101)
Interviews (325)
IPO (16905)
IRA (43)
Job creations (3739)
Job search strategy (1465)
Kidney cancer (11)
Labor market (43)
Layoffs (522)
Leadership (18)
Legal (8083)
Liver cancer (79)
Lung cancer (350)
Lymphoma (164)
Machine learning (9)
Management (58)
Manufacturing (352)
MASH (82)
Medical device (13629)
Medtech (13634)
Mergers & acquisitions (19914)
Metabolic disorders (752)
Multiple sclerosis (87)
NASH (19)
Neurodegenerative disease (111)
Neuropsychiatric disorders (33)
Neuroscience (2064)
NextGen: Class of 2025 (6838)
Non-profit (4618)
Now hiring (40)
Obesity (399)
Opinion (229)
Ovarian cancer (84)
Pain (96)
Pancreatic cancer (90)
Parkinson's disease (162)
Partnered (22)
Patents (253)
Patient recruitment (119)
Peanut (48)
People (59229)
Pharmaceutical (90)
Pharmacy benefit managers (21)
Phase I (21680)
Phase II (30379)
Phase III (22478)
Pipeline (1457)
Policy (159)
Postmarket research (2662)
Preclinical (9538)
Press Release (70)
Prostate cancer (113)
Psychedelics (37)
Radiopharmaceuticals (265)
Rare diseases (424)
Real estate (6111)
Recruiting (67)
Regulatory (23160)
Reports (48)
Research institute (2512)
Resumes & cover letters (360)
Rett syndrome (6)
RNA editing (5)
RSV (44)
Schizophrenia (80)
Series A (144)
Series B (97)
Service/supplier (11)
Sickle cell disease (59)
Special edition (19)
Spinal muscular atrophy (157)
Sponsored (31)
Startups (3796)
State (2)
Stomach cancer (16)
Supply chain (70)
Tariffs (51)
The Weekly (58)
Vaccines (746)
Venture capitalists (44)
Weight loss (263)
Women's health (38)
Worklife (17)
Date
Today (162)
Last 7 days (1031)
Last 30 days (3429)
Last 365 days (33866)
2025 (12552)
2024 (36672)
2023 (41368)
2022 (52662)
2021 (57165)
2020 (55396)
2019 (47954)
2018 (36139)
2017 (33594)
2016 (33047)
2015 (39131)
2014 (32929)
2013 (28283)
2012 (30299)
2011 (30734)
2010 (28849)
Location
Africa (763)
Alabama (59)
Alaska (7)
Arizona (244)
Arkansas (14)
Asia (40550)
Australia (6932)
California (6650)
Canada (2093)
China (561)
Colorado (286)
Connecticut (296)
Delaware (164)
Europe (89774)
Florida (969)
Georgia (217)
Idaho (58)
Illinois (573)
India (25)
Indiana (328)
Iowa (12)
Japan (177)
Kansas (110)
Kentucky (26)
Louisiana (12)
Maine (71)
Maryland (950)
Massachusetts (5048)
Michigan (228)
Minnesota (415)
Mississippi (2)
Missouri (83)
Montana (29)
Nebraska (26)
Nevada (68)
New Hampshire (67)
New Jersey (1844)
New Mexico (31)
New York (1853)
North Carolina (1075)
North Dakota (9)
Northern California (2908)
Ohio (214)
Oklahoma (14)
Oregon (38)
Pennsylvania (1461)
Puerto Rico (14)
Rhode Island (34)
South America (1161)
South Carolina (26)
South Dakota (1)
Southern California (2479)
Tennessee (106)
Texas (989)
United States (24992)
Utah (191)
Virginia (160)
Washington D.C. (66)
Washington State (598)
West Virginia (3)
Wisconsin (60)
731,353 Results for "lineage cell therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 14, 2025
·
15 min read
Press Releases
Lineage Cell Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025
May 1, 2025
·
2 min read
Press Releases
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor Symposium
April 22, 2025
·
8 min read
Press Releases
Lineage Cell Therapeutics Issues Letter to Stockholders
January 7, 2025
·
16 min read
Press Releases
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 10, 2025
·
19 min read
Press Releases
Lineage Cell Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Lifesciences Conference
February 4, 2025
·
2 min read
Press Releases
Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering
January 27, 2025
·
6 min read
Press Releases
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on March 10, 2025
March 5, 2025
·
2 min read
Business
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Lineage Cell Therapeutics, Inc. reported its first quarter 2024 financial and operating results and will host a conference call at 4:30 p.m. Eastern Time to discuss these results and to provide a business update.
May 9, 2024
·
16 min read
Business
Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
Lineage Cell Therapeutics, Inc. today announced that it will report its first quarter 2024 financial and operating results on Thursday, May 9, 2024, following the close of the U.S. financial markets.
May 2, 2024
·
3 min read
1 of 73,136
Next
